Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma

Rubin Wang, Jenny C. Titley, Yong Jie Lu, Brenda M. Summersgill, Julia A. Bridge, Cyril Fisher, Janet Shipley

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Leiomyosarcomas of soft tissues are an aggressive group of tumors with a high incidence of recurrence. Little is known about the molecular genetic changes associated with clinical outcome. Therefore, we studied 28 leiomyosarcoma samples of similar grade using comparative genomic hybridization and DNA flow cytometry and identified a difference in survival time associated with ploidy status and the number of chromosomal aberrations. The average survival time was shown to decrease with increase in chromosomal aberrations identified using comparative genomic hybridization. The average survival time was shorter in the near-tetraploid group than in the diploid and triploid group. Gain of 5p14-pter was significantly more common in near-tetraploid tumors. The survival time of patients with near-tetraploidy together with gain of 5p14-pter was reduced, and 50% died within the 1st year. Furthermore, loss of 13q14-q21 was significantly more frequent in the <5-year than in the >5-year survival group (P = .01). These results suggest that 13q14-q21 loss and 5p14-pter gain at diagnosis could be used to identify patients with leiomyosarcoma who are likely to have a shorter survival time and who might benefit from early treatment intensification.

Original languageEnglish (US)
Pages (from-to)778-785
Number of pages8
JournalModern Pathology
Volume16
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Leiomyosarcoma
Tetraploidy
Survival
Comparative Genomic Hybridization
Chromosome Aberrations
Triploidy
Ploidies
Diploidy
Molecular Biology
Neoplasms
Flow Cytometry
Recurrence
DNA
Incidence

Keywords

  • Chromosome
  • Comparative genomic hybridization
  • Flow cytometry
  • Leiomyosarcoma
  • Progression

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Wang, R., Titley, J. C., Lu, Y. J., Summersgill, B. M., Bridge, J. A., Fisher, C., & Shipley, J. (2003). Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Modern Pathology, 16(8), 778-785. https://doi.org/10.1097/01.MP.0000083648.45923.2B

Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. / Wang, Rubin; Titley, Jenny C.; Lu, Yong Jie; Summersgill, Brenda M.; Bridge, Julia A.; Fisher, Cyril; Shipley, Janet.

In: Modern Pathology, Vol. 16, No. 8, 01.08.2003, p. 778-785.

Research output: Contribution to journalArticle

Wang, R, Titley, JC, Lu, YJ, Summersgill, BM, Bridge, JA, Fisher, C & Shipley, J 2003, 'Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma', Modern Pathology, vol. 16, no. 8, pp. 778-785. https://doi.org/10.1097/01.MP.0000083648.45923.2B
Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C et al. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Modern Pathology. 2003 Aug 1;16(8):778-785. https://doi.org/10.1097/01.MP.0000083648.45923.2B
Wang, Rubin ; Titley, Jenny C. ; Lu, Yong Jie ; Summersgill, Brenda M. ; Bridge, Julia A. ; Fisher, Cyril ; Shipley, Janet. / Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. In: Modern Pathology. 2003 ; Vol. 16, No. 8. pp. 778-785.
@article{b910b466edd54622b8e0fd71e7664a9a,
title = "Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma",
abstract = "Leiomyosarcomas of soft tissues are an aggressive group of tumors with a high incidence of recurrence. Little is known about the molecular genetic changes associated with clinical outcome. Therefore, we studied 28 leiomyosarcoma samples of similar grade using comparative genomic hybridization and DNA flow cytometry and identified a difference in survival time associated with ploidy status and the number of chromosomal aberrations. The average survival time was shown to decrease with increase in chromosomal aberrations identified using comparative genomic hybridization. The average survival time was shorter in the near-tetraploid group than in the diploid and triploid group. Gain of 5p14-pter was significantly more common in near-tetraploid tumors. The survival time of patients with near-tetraploidy together with gain of 5p14-pter was reduced, and 50{\%} died within the 1st year. Furthermore, loss of 13q14-q21 was significantly more frequent in the <5-year than in the >5-year survival group (P = .01). These results suggest that 13q14-q21 loss and 5p14-pter gain at diagnosis could be used to identify patients with leiomyosarcoma who are likely to have a shorter survival time and who might benefit from early treatment intensification.",
keywords = "Chromosome, Comparative genomic hybridization, Flow cytometry, Leiomyosarcoma, Progression",
author = "Rubin Wang and Titley, {Jenny C.} and Lu, {Yong Jie} and Summersgill, {Brenda M.} and Bridge, {Julia A.} and Cyril Fisher and Janet Shipley",
year = "2003",
month = "8",
day = "1",
doi = "10.1097/01.MP.0000083648.45923.2B",
language = "English (US)",
volume = "16",
pages = "778--785",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma

AU - Wang, Rubin

AU - Titley, Jenny C.

AU - Lu, Yong Jie

AU - Summersgill, Brenda M.

AU - Bridge, Julia A.

AU - Fisher, Cyril

AU - Shipley, Janet

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Leiomyosarcomas of soft tissues are an aggressive group of tumors with a high incidence of recurrence. Little is known about the molecular genetic changes associated with clinical outcome. Therefore, we studied 28 leiomyosarcoma samples of similar grade using comparative genomic hybridization and DNA flow cytometry and identified a difference in survival time associated with ploidy status and the number of chromosomal aberrations. The average survival time was shown to decrease with increase in chromosomal aberrations identified using comparative genomic hybridization. The average survival time was shorter in the near-tetraploid group than in the diploid and triploid group. Gain of 5p14-pter was significantly more common in near-tetraploid tumors. The survival time of patients with near-tetraploidy together with gain of 5p14-pter was reduced, and 50% died within the 1st year. Furthermore, loss of 13q14-q21 was significantly more frequent in the <5-year than in the >5-year survival group (P = .01). These results suggest that 13q14-q21 loss and 5p14-pter gain at diagnosis could be used to identify patients with leiomyosarcoma who are likely to have a shorter survival time and who might benefit from early treatment intensification.

AB - Leiomyosarcomas of soft tissues are an aggressive group of tumors with a high incidence of recurrence. Little is known about the molecular genetic changes associated with clinical outcome. Therefore, we studied 28 leiomyosarcoma samples of similar grade using comparative genomic hybridization and DNA flow cytometry and identified a difference in survival time associated with ploidy status and the number of chromosomal aberrations. The average survival time was shown to decrease with increase in chromosomal aberrations identified using comparative genomic hybridization. The average survival time was shorter in the near-tetraploid group than in the diploid and triploid group. Gain of 5p14-pter was significantly more common in near-tetraploid tumors. The survival time of patients with near-tetraploidy together with gain of 5p14-pter was reduced, and 50% died within the 1st year. Furthermore, loss of 13q14-q21 was significantly more frequent in the <5-year than in the >5-year survival group (P = .01). These results suggest that 13q14-q21 loss and 5p14-pter gain at diagnosis could be used to identify patients with leiomyosarcoma who are likely to have a shorter survival time and who might benefit from early treatment intensification.

KW - Chromosome

KW - Comparative genomic hybridization

KW - Flow cytometry

KW - Leiomyosarcoma

KW - Progression

UR - http://www.scopus.com/inward/record.url?scp=0041387331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041387331&partnerID=8YFLogxK

U2 - 10.1097/01.MP.0000083648.45923.2B

DO - 10.1097/01.MP.0000083648.45923.2B

M3 - Article

C2 - 12920222

AN - SCOPUS:0041387331

VL - 16

SP - 778

EP - 785

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 8

ER -